StockData
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. (PPCB) stock

PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$1.94+0.02 (+1.09%)

Close on Nov 13, 2026Market cap $12.29MP/E –Yield –

Propanc Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Propanc Biopharma's market cap was $6.09M on Nov 11, 2026, against $286.10M a year earlier. Over the last 5 years it ranged from $30 to $29.00B, with a median of $519.20K.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.09M-96.5%
2025Dec 31, 2025$171.80M+149393399.1%
2024Dec 31, 2024$115-22.3%
2023Dec 29, 2023$148-100.0%
2022Dec 30, 2022$338.67K-78.9%
2021Dec 31, 2021$1.61M+92.6%
2020Dec 31, 2020$835.10K+43852.6%
2019Dec 31, 2019$1.90K+6233.3%
2018Dec 31, 2018$30–

More Propanc Biopharma figures

See a number that looks wrong?